GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CrystalGenomics Invites Co Ltd (XKRX:083790) » Definitions » EV-to-FCF

CrystalGenomics Invites Co (XKRX:083790) EV-to-FCF : -3.48 (As of Jun. 24, 2024)


View and export this data going back to 2006. Start your Free Trial

What is CrystalGenomics Invites Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, CrystalGenomics Invites Co's Enterprise Value is ₩195,939.0 Mil. CrystalGenomics Invites Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-56,258.9 Mil. Therefore, CrystalGenomics Invites Co's EV-to-FCF for today is -3.48.

The historical rank and industry rank for CrystalGenomics Invites Co's EV-to-FCF or its related term are showing as below:

XKRX:083790' s EV-to-FCF Range Over the Past 10 Years
Min: -894.58   Med: -61.53   Max: 1967.9
Current: -3.48

During the past 13 years, the highest EV-to-FCF of CrystalGenomics Invites Co was 1967.90. The lowest was -894.58. And the median was -61.53.

XKRX:083790's EV-to-FCF is ranked worse than
100% of 397 companies
in the Biotechnology industry
Industry Median: 6.4 vs XKRX:083790: -3.48

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-24), CrystalGenomics Invites Co's stock price is ₩2535.00. CrystalGenomics Invites Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-710.000. Therefore, CrystalGenomics Invites Co's PE Ratio for today is At Loss.


CrystalGenomics Invites Co EV-to-FCF Historical Data

The historical data trend for CrystalGenomics Invites Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CrystalGenomics Invites Co EV-to-FCF Chart

CrystalGenomics Invites Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -120.05 -46.08 -18.39 -6.00 -3.45

CrystalGenomics Invites Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.60 -6.39 -3.36 -3.45 -5.13

Competitive Comparison of CrystalGenomics Invites Co's EV-to-FCF

For the Biotechnology subindustry, CrystalGenomics Invites Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CrystalGenomics Invites Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CrystalGenomics Invites Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where CrystalGenomics Invites Co's EV-to-FCF falls into.



CrystalGenomics Invites Co EV-to-FCF Calculation

CrystalGenomics Invites Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=195938.982/-56258.875
=-3.48

CrystalGenomics Invites Co's current Enterprise Value is ₩195,939.0 Mil.
CrystalGenomics Invites Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-56,258.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CrystalGenomics Invites Co  (XKRX:083790) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

CrystalGenomics Invites Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2535.00/-710.000
=At Loss

CrystalGenomics Invites Co's share price for today is ₩2535.00.
CrystalGenomics Invites Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-710.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


CrystalGenomics Invites Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of CrystalGenomics Invites Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


CrystalGenomics Invites Co (XKRX:083790) Business Description

Traded in Other Exchanges
N/A
Address
5F, A-dong, Korea Bio Park, 694-1, Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi, KOR, 463-400
CrystalGenomics Invites Co Ltd Formerly CrystalGenomics Inc is one of the leading biopharmaceutical company in Korea. The company is mainly engaged in the research and development and new drug development. It develops innovative new drug development projects such as eradication antibiotics and molecular targeted anticancer drugs. It focuses on arthritic medicines and antibiotics which kill resistant bacteria. It also offers medicines for cancer, obesity, asthma, and diabetes.

CrystalGenomics Invites Co (XKRX:083790) Headlines

No Headlines